Idiopathic intracranial hypertension: Difference between revisions

No edit summary
No edit summary
Line 3: Line 3:
*May be due to impaired arachnoid villi absorption
*May be due to impaired arachnoid villi absorption
*Associated with OCPs, vitamin A, tetracycline, and thyroid disorders
*Associated with OCPs, vitamin A, tetracycline, and thyroid disorders
==Clinical Features==
#Headache
#N/V
#Vision blurring


==Diagnosis==
==Diagnosis==
Line 12: Line 17:
==Work-Up==
==Work-Up==
#CT scan (negative)
#CT scan (negative)
#LP (CSF pressure 25-40)  
#LP (Opening pressure >25)  


==Treatment==
==Treatment==
#Repeate LPs (decrease CSF pressure)
#Repeat LPs (decrease CSF pressure)
#Acetazolamide 250mg BID
#Acetazolamide 500mg BID
#Weight loss
#Weight loss
#CSF Shunt
#CSF Shunt
Line 26: Line 31:
**Focal findings
**Focal findings
**Vision changes
**Vision changes
*Otherwise, discharge w/ ophtho f/u for formal visual field monitoring


==Source==
==Source==

Revision as of 21:20, 29 October 2011

Background

  • Also known as pseudotumor cerebri
  • May be due to impaired arachnoid villi absorption
  • Associated with OCPs, vitamin A, tetracycline, and thyroid disorders

Clinical Features

  1. Headache
  2. N/V
  3. Vision blurring

Diagnosis

  1. Young, obese women
  2. Headache (worse in AM / with manuvers increasing ICP)
  3. Papilledema (optic atrophy/vision loss)
  4. Neuro exam frequently normal

Work-Up

  1. CT scan (negative)
  2. LP (Opening pressure >25)

Treatment

  1. Repeat LPs (decrease CSF pressure)
  2. Acetazolamide 500mg BID
  3. Weight loss
  4. CSF Shunt
  5. Optic nerve sheath fenestration

Disposition

  • Admit for:
    • Severe pain
    • Focal findings
    • Vision changes
  • Otherwise, discharge w/ ophtho f/u for formal visual field monitoring

Source

Tintinalli